Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease
Clinical trial NCT05400330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05400330
- Sponsor
- Lexeo Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2028-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.